Objective: To investigate the feasibility and effectiveness of percutaneous ethanol injection of anhydrous alcohol in the treatment of hepatocellular carcinoma with contrast-enhanced ultrasound. Methods: 86 patients with primary liver cancer who were confirmed by pathology in our hospital from March 2013 to May 2015, 107 patients with liver cancer were treated by percutaneous ethanol injection of anhydrous alcohol.